Organoid cultures derived from patients with advanced prostate cancer (Q34545103)

2 August 2017

Organoid cultures derived from patients with advanced prostate cancer (English)

1 reference

2 August 2017

1 reference

1 reference

Dong Gao

1

0 references

Dana E Rathkopf

Dana E Rathkopf

27

0 references

Michael J. Morris

Michael J Morris

28

0 references

Mark Rubin

Mark A Rubin

35

0 references

Hans Clevers

37

Hans Clevers

1 reference

2 August 2017

10

Vivek K Arora

1 reference

2 August 2017

21

Himisha Beltran

1 reference

2 August 2017

3

Andrea Sboner

1 reference

2 August 2017

22

Juan-Miguel Mosquera

1 reference

2 August 2017

5

Wouter R Karthaus

1 reference

2 August 2017

12

Myriam Kossai

1 reference

2 August 2017

11

John Wongvipat

1 reference

2 August 2017

29

Daniel C Danila

1 reference

2 August 2017

Ian Vela

2

1 reference

2 August 2017

Phillip J Iaquinta

4

1 reference

2 August 2017

Anuradha Gopalan

6

1 reference

2 August 2017

Catherine Dowling

7

1 reference

2 August 2017

Jackline N Wanjala

8

1 reference

2 August 2017

Eva A Undvall

9

1 reference

2 August 2017

Sinan Ramazanoglu

13

1 reference

2 August 2017

Luendreo P Barboza

14

1 reference

2 August 2017

Wei Di

15

1 reference

2 August 2017

Zhen Cao

16

1 reference

2 August 2017

Qi Fan Zhang

17

1 reference

2 August 2017

Inna Sirota

18

1 reference

2 August 2017

Leili Ran

19

1 reference

2 August 2017

Theresa Y MacDonald

20

1 reference

2 August 2017

Karim A Touijer

23

1 reference

2 August 2017

Peter T Scardino

24

1 reference

2 August 2017

Vincent P Laudone

25

1 reference

2 August 2017

Kristen R Curtis

26

1 reference

2 August 2017

Susan F Slovin

30

1 reference

2 August 2017

Stephen B Solomon

31

1 reference

2 August 2017

James A Eastham

32

1 reference

2 August 2017

Ping Chi

33

1 reference

2 August 2017

Brett Carver

34

1 reference

2 August 2017

Howard I Scher

36

1 reference

2 August 2017

Charles L Sawyers

38

1 reference

2 August 2017

Yu Chen

39

1 reference

2 August 2017

language of work or name

English

0 references

publication date

4 September 2014

1 reference

2 August 2017

1 reference

2 August 2017

159

1 reference

2 August 2017

176-187

1 reference

2 August 2017

1

1 reference

Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Punctuated evolution of prostate cancer genomes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Overcoming mutation-based resistance to antiandrogens with rational drug design

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Androgen receptor antagonists in castration-resistant prostate cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

STAR: ultrafast universal RNA-seq aligner

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Increased survival with enzalutamide in prostate cancer after chemotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

The mutational landscape of lethal castration-resistant prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Systematic identification of genomic markers of drug sensitivity in cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Integrated genomic analyses of ovarian carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Abiraterone and increased survival in metastatic prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Improving RNA-Seq expression estimates by correcting for fragment bias

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Integrative genomic profiling of human prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Fast and accurate long-read alignment with Burrows-Wheeler transform

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Distinct genomic aberrations associated with ERG rearranged prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

The role of SPINK1 in ETS rearrangement-negative prostate cancers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

BRAF mutation predicts sensitivity to MEK inhibition

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Prostate carcinoma with squamous differentiation: an analysis of 33 cases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

VCaP, a cell-based model system of human prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

A new human prostate carcinoma cell line, 22Rv1.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Establishment of two human prostate cancer cell lines derived from a single bone metastasis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

LNCaP model of human prostatic carcinoma.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237931

Prostate carcinoma: tissue culture cell lines

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25201530

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.CELL.2014.08.016

1 reference

2 August 2017

1 reference

2 August 2017

1 reference